- Home
- SKYE vs WRAP Comparison
SKYE vs WRAP Comparison
Compare SKYE & WRAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- WRAP
- Stock Information
- Founded
- SKYE 2012
- WRAP 2016
- Country
- SKYE United States
- WRAP United States
- Employees
- SKYE N/A
- WRAP N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- WRAP Ordnance And Accessories
- Sector
- SKYE Health Care
- WRAP Industrials
- Exchange
- SKYE Nasdaq
- WRAP Nasdaq
- Market Cap
- SKYE 121.8M
- WRAP 104.2M
- IPO Year
- SKYE N/A
- WRAP N/A
- Fundamental
- Price
- SKYE $1.33
- WRAP $2.56
- Analyst Decision
- SKYE Strong Buy
- WRAP
- Analyst Count
- SKYE 5
- WRAP 0
- Target Price
- SKYE $14.75
- WRAP N/A
- AVG Volume (30 Days)
- SKYE 1.8M
- WRAP 384.0K
- Earning Date
- SKYE 11-06-2025
- WRAP 11-12-2025
- Dividend Yield
- SKYE N/A
- WRAP N/A
- EPS Growth
- SKYE N/A
- WRAP N/A
- EPS
- SKYE N/A
- WRAP N/A
- Revenue
- SKYE N/A
- WRAP $3,236,000.00
- Revenue This Year
- SKYE N/A
- WRAP N/A
- Revenue Next Year
- SKYE N/A
- WRAP N/A
- P/E Ratio
- SKYE N/A
- WRAP N/A
- Revenue Growth
- SKYE N/A
- WRAP N/A
- 52 Week Low
- SKYE $1.14
- WRAP $1.20
- 52 Week High
- SKYE $5.96
- WRAP $3.00
- Technical
- Relative Strength Index (RSI)
- SKYE 27.04
- WRAP 54.89
- Support Level
- SKYE $1.50
- WRAP $2.23
- Resistance Level
- SKYE $1.76
- WRAP $2.64
- Average True Range (ATR)
- SKYE 0.24
- WRAP 0.23
- MACD
- SKYE -0.15
- WRAP -0.06
- Stochastic Oscillator
- SKYE 0.68
- WRAP 42.28
About SKYE Skye Bioscience Inc.
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.